↓ Skip to main content

Cochrane Database of Systematic Reviews

Botulinum toxin injections for adults with overactive bladder syndrome

Overview of attention for article published in this source, December 2011
Altmetric Badge

Mentioned by

news
2 news outlets
blogs
2 blogs
policy
1 policy source
twitter
1 X user
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
188 Dimensions

Readers on

mendeley
164 Mendeley
Title
Botulinum toxin injections for adults with overactive bladder syndrome
Published by
John Wiley & Sons, Ltd, December 2011
DOI 10.1002/14651858.cd005493.pub3
Pubmed ID
Authors

Duthie, James B, Vincent, Michael, Herbison, G Peter, Wilson, David Iain, Wilson, Don

Abstract

Overactive bladder syndrome (OAB) is a common condition with a significant negative impact on quality of life characterised by urgency with or without urge incontinence, frequency and nocturia.  Intravesical botulinum toxin is being increasingly used to treat severe overactive bladder refractory to standard management.  An increasing body of literature is forming that supports this technique as effective, well tolerated, and safe.  This review is a substantial update of the 2007 review of the same title.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 164 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Belgium 1 <1%
Brazil 1 <1%
Unknown 161 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 16%
Student > Bachelor 19 12%
Researcher 17 10%
Student > Ph. D. Student 15 9%
Student > Doctoral Student 12 7%
Other 38 23%
Unknown 37 23%
Readers by discipline Count As %
Medicine and Dentistry 78 48%
Nursing and Health Professions 10 6%
Agricultural and Biological Sciences 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Social Sciences 5 3%
Other 20 12%
Unknown 41 25%